1st Quarter - Report

ILLUMINA, INC. for ILLUMINA, INC.

Period 1st Quarter 2022 Filed Apr 20, 2022 Signed by Jason D. Kaune, Attorney & Agent for Filer

Official filing
Firm
ILLUMINA, INC.
Client
ILLUMINA, INC.
Income
—
Expenses
$1,960,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R. 6000: Cures 2.0 Act; all provisions S. 2022: Ending the Diagnostic Odyssey Act of 2021; all provisions S. 3799: Prepare for and Respond to Existing Viruses, Emerging New Threats, and Pandemics (PREVENT Pandemics) Act; all provisions General discussions related to genomics, sequencing and applications for sequencing technologies

LobbyistCovered position, as disclosed
BRIAN CHRISTOPHER TOOHEY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 6000 (117th), S. 3799 (117th), S. 2022 (117th)

Government Issues GOV

General discussions related to competition, access, and regulatory actions regarding Multi-Cancer Early Detection technology

LobbyistCovered position, as disclosed
BRIAN CHRISTOPHER TOOHEY —

Contacted: HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.